2013
DOI: 10.3390/ijms141224412
|View full text |Cite
|
Sign up to set email alerts
|

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease

Abstract: There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) may contribute to endothelial dysfunction. Studies in animal models as well as in humans have suggested that the increase in ADMA occurs at a time when vascular disease has not yet become clinically evident. ADMA competitively inhibits NO elaboration by displacing l-arginine from NO synthase. In a concentration-dependent manner, it thereby interferes not only with endothelium-dependent, NO… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
30
0
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 42 publications
1
30
0
2
Order By: Relevance
“…At the same time, the effects of inhibitors on farrerol-induced rat aorta relaxation were studied using 0.1 mM L-NAME [47,48], a NO synthesis inhibitor. When the contraction induced by 60 mM KCl or 1 μM PE reached a sustained plateau, L-NAME was added to the chamber.…”
Section: Methodsmentioning
confidence: 99%
“…At the same time, the effects of inhibitors on farrerol-induced rat aorta relaxation were studied using 0.1 mM L-NAME [47,48], a NO synthesis inhibitor. When the contraction induced by 60 mM KCl or 1 μM PE reached a sustained plateau, L-NAME was added to the chamber.…”
Section: Methodsmentioning
confidence: 99%
“…NO is a potent vasodilator that plays a critical role in maintaining vascular homeostasis through its anti-atherogenic and anti-proliferative effects on the vascular wall [1]. …”
Section: Introductionmentioning
confidence: 99%
“…Both the inhibition of NO synthase by ADMA and oxidant/ antioxidant imbalance may contribute to decreased bioavailability of NO in BD. High level of serum ADMA has been suggested to be an independent risk factor for ED, coronary heart disease, and cardiovascular mortality [8,[22][23][24]. Increased serum ADMA level was shown to be independently associated with contrast-induced nephropathy in patients with chronic renal disease who underwent coronary angiography [25].…”
Section: Discussionmentioning
confidence: 99%